From Name:
From Email:
To Name:
To Email:

Optional Message:

Protecting Hearts From Herceptin: MANTICORE Data 'Unclear'

from Medscape

Antihypertensive pharmacotherapy can prevent chemotherapy-related cardiac dysfunction and life-threatening treatment interruptions in patients with invasive early breast cancer given adjuvant trastuzumab, show the now-published results from five-year Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE) trial. However, neither of the pharmacotherapies prevented trastuzumab-mediated concurrent left ventricular (LV) end-diastolic volume — also known as LV remodeling — which was the study's primary endpoint. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063